KR20040074134A - 2'-할로-3',5'-디알콕시펜-1'-일-이미노-2-이미다졸리딘유도체 및 요실금의 치료를 위한 이의 용도 - Google Patents

2'-할로-3',5'-디알콕시펜-1'-일-이미노-2-이미다졸리딘유도체 및 요실금의 치료를 위한 이의 용도 Download PDF

Info

Publication number
KR20040074134A
KR20040074134A KR10-2004-7011589A KR20047011589A KR20040074134A KR 20040074134 A KR20040074134 A KR 20040074134A KR 20047011589 A KR20047011589 A KR 20047011589A KR 20040074134 A KR20040074134 A KR 20040074134A
Authority
KR
South Korea
Prior art keywords
imidazolidine
imino
formula
compound
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR10-2004-7011589A
Other languages
English (en)
Korean (ko)
Inventor
에서프란츠
푸젯파스칼
이시구로나오키
기타가와히사토
무라마쓰이쿠노부
Original Assignee
베링거 잉겔하임 파르마 게엠베하 운트 코 카게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 filed Critical 베링거 잉겔하임 파르마 게엠베하 운트 코 카게
Publication of KR20040074134A publication Critical patent/KR20040074134A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR10-2004-7011589A 2002-01-31 2002-12-16 2'-할로-3',5'-디알콕시펜-1'-일-이미노-2-이미다졸리딘유도체 및 요실금의 치료를 위한 이의 용도 Withdrawn KR20040074134A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02002352A EP1333028A1 (en) 2002-01-31 2002-01-31 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
EP02002352.9 2002-01-31
PCT/EP2002/014299 WO2003064398A1 (en) 2002-01-31 2002-12-16 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
KR20040074134A true KR20040074134A (ko) 2004-08-21

Family

ID=8185397

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7011589A Withdrawn KR20040074134A (ko) 2002-01-31 2002-12-16 2'-할로-3',5'-디알콕시펜-1'-일-이미노-2-이미다졸리딘유도체 및 요실금의 치료를 위한 이의 용도

Country Status (20)

Country Link
EP (2) EP1333028A1 (enExample)
JP (1) JP2005516066A (enExample)
KR (1) KR20040074134A (enExample)
CN (1) CN1617857A (enExample)
AR (1) AR038380A1 (enExample)
BR (1) BR0215560A (enExample)
CA (1) CA2474588A1 (enExample)
EA (1) EA200400877A1 (enExample)
EC (1) ECSP045210A (enExample)
HR (1) HRP20040691A2 (enExample)
HU (1) HUP0402654A2 (enExample)
IL (1) IL162776A0 (enExample)
MX (1) MXPA04007250A (enExample)
NO (1) NO20043614L (enExample)
PE (1) PE20030819A1 (enExample)
PL (1) PL369826A1 (enExample)
TW (1) TW200418462A (enExample)
UY (1) UY27628A1 (enExample)
WO (1) WO2003064398A1 (enExample)
ZA (1) ZA200405173B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体
AU2009246600A1 (en) 2008-05-13 2009-11-19 Allergan, Inc. Naphthylmethylimidizoles for the treatment of stress urinary incontinence
EP2296655A1 (en) * 2008-05-13 2011-03-23 Allergan, Inc. Quinolynylmethylimidizoles as therapeutic agents
US8071636B2 (en) * 2008-06-09 2011-12-06 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions
WO2009152053A1 (en) * 2008-06-09 2009-12-17 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions using imidazoline derivates
US9034910B2 (en) 2008-06-09 2015-05-19 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2220906A1 (de) * 1972-04-28 1973-11-15 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2259160A1 (de) * 1972-12-02 1974-06-06 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline, deren saeureadditionssalze und verfahren zur herstellung derselben sowie ihre verwendung als arzneimittel
AT333749B (de) * 1974-07-03 1976-12-10 Chemie Linz Ag Verfahren zur herstellung von neuen 2-arylamino-2-imidazolinderivaten
MTP837B (en) * 1977-11-07 1979-10-22 Hoffman La Roche And Co Aktien Derivatives 2 finino-imidazolidire
DE3514351A1 (de) * 1985-04-20 1986-11-06 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
DE19740176C2 (de) * 1997-09-12 2000-04-06 Lemfoerder Metallwaren Ag Handschaltvorrichtung für ein Kraftfahrzeug

Also Published As

Publication number Publication date
AR038380A1 (es) 2005-01-12
BR0215560A (pt) 2004-12-21
WO2003064398A1 (en) 2003-08-07
NO20043614L (no) 2004-08-30
TW200418462A (en) 2004-10-01
EP1333028A1 (en) 2003-08-06
PL369826A1 (en) 2005-05-02
HRP20040691A2 (en) 2004-12-31
UY27628A1 (es) 2003-08-29
ZA200405173B (en) 2005-06-21
PE20030819A1 (es) 2003-10-20
HUP0402654A2 (hu) 2005-03-29
MXPA04007250A (es) 2004-10-29
EA200400877A1 (ru) 2005-02-24
CN1617857A (zh) 2005-05-18
CA2474588A1 (en) 2003-08-07
IL162776A0 (en) 2005-11-20
EP1472231A1 (en) 2004-11-03
JP2005516066A (ja) 2005-06-02
ECSP045210A (es) 2004-09-28

Similar Documents

Publication Publication Date Title
JP3379960B2 (ja) 尿失禁を治療するためのα▲下１Ｌ▼アゴニストの使用
JPH05500226A (ja) 新規キサンチン化合物
JP2002507603A (ja) イミダゾロン食欲抑制薬：ｉ．非環式誘導体
KR0150649B1 (ko) 술폰아닐리드 유도체 및 의약
US20050137233A1 (en) Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amide
KR20040074134A (ko) 2'-할로-3',5'-디알콕시펜-1'-일-이미노-2-이미다졸리딘유도체 및 요실금의 치료를 위한 이의 용도
JPS6242905B2 (enExample)
US4239768A (en) Method for relieving irritable bowel syndrome symptoms
US20220009951A1 (en) Torsemide phosphate prodrug, preparation method and composition thereof
EP4559923A1 (en) Antihistamine compound, and preparation method therefor and use thereof
US6703409B2 (en) 2′-Halo-3′,5′-dialkoxyphen-1′-yl-imino-2-imidazolidine and the use thereof as a drug
JP4567889B2 (ja) （（アミノイミノメチル）アミノ）アルカンカルボキシアミドおよび治療におけるその適用
HUT77907A (hu) 2-Metil-4-(4-metil-piperazino)-1OH-tieno[2,3-b][1,5] benzodiazepin alkalmazása kognitiv diszfunkció kezelésére gyógyszerkészítmények előállítására
AU2002360984A1 (en) 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
GB2033900A (en) Sulphonamides
JP2001519828A (ja) α▲下２▼−アドレナリン受容体作動薬として有用な５−（２−イミダゾリニルアミノ）ベンゾイミダゾール化合物類
JP2004517158A (ja) 尿失禁を治療するための２−アミノ−１−（４−ヒドロキシ−２−メタンスルホンアミドフェニル）エタノールの使用
EP4559922A1 (en) Antihistamine compound, preparation method therefor and use thereof
US6660772B2 (en) Use of 2-amino-1-(4-hydroxy-2-methanesulfonamidophenyl)ethanol for treating urinary incontinence
JPH06107546A (ja) Ａｄｍ耐性解除剤
EP0337350A2 (en) Use of dimethylheptylphenyl butanoyl ethanolamine in treatment of hyperuricemia
CN110577475A (zh) 一种氨溴索衍生物及其制方、药物组合物与用途
EP2626349A1 (en) Amine compound and use for same
CA2015013A1 (en) Triazole compound, antimycotic preparation containing same, and method for the prevention and/or treatment of deep-seated mycosis by using same
HK1081553B (en) Novel prodrugs of 1-methyl-2(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridil-n-2-hydroxycarbonylethyl)-amide, production and use thereof as medicaments

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20040727

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid